UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032903
Receipt number R000037517
Scientific Title Effects of Plasma Exchange on Survival in Patients with Postoperative Liver Failure
Date of disclosure of the study information 2018/06/07
Last modified on 2018/06/07 12:32:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Plasma Exchange on Survival in Patients with Postoperative Liver Failure

Acronym

Effects of Plasma Exchange in Patients with Postoperative Liver Failure

Scientific Title

Effects of Plasma Exchange on Survival in Patients with Postoperative Liver Failure

Scientific Title:Acronym

Effects of Plasma Exchange in Patients with Postoperative Liver Failure

Region

Japan


Condition

Condition

Postoperative hepatic failure

Classification by specialty

Gastroenterology Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Postoperative hepatic failure (POLF) syndrome is recently decreased by the progress of surgical techniques, critical care, and postoperative treatment. However, management of POLF still remains a challenge and when it worsens, it turns to be a significant source of morbidity and mortality. Plasma exchange (PE) is used as a salvage strategy for POLF in some countries, especially in Japan. Several authors have reported the usefulness of PE for POLF syndrome, which were conducted in 1990 to 2000. We conducted retrospective single center study to investigate effects of patients with POLF treated with PE.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

SOFA score

Key secondary outcomes

patient outcomes, Glasgow Coma Scale (GCS), prothrombin time, serum total bilirubin level


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects of this study were included patients with postoperative liver failure who admitted to the ICU and were performed with PE. The definition of postoperative liver failure was persistent hyperbilirubinemia.

Key exclusion criteria

Under 20 year old

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiro Kobe

Organization

Graduate School of Medicine, Chiba University

Division name

Eastern Chiba Medical Center

Zip code


Address

3-6-2 Okayamadai, Togane, Chiba prefecture

TEL

0475-50-1199

Email

y-kobe@umin.org


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiro Kobe

Organization

Graduate School of Medicine, Chiba University

Division name

Eastern Chiba Medical Center

Zip code


Address

3-6-2 Okayamadai, Togane, Chiba prefecture

TEL

0475-50-1199

Homepage URL


Email

y-kobe@umin.org


Sponsor or person

Institute

Chiba university

Institute

Department

Personal name



Funding Source

Organization

Chiba university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 16 Day

Date of IRB


Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The study was already finished.


Management information

Registered date

2018 Year 06 Month 07 Day

Last modified on

2018 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037517


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name